Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations —Going beyond the body‐size effect

This study approach may be applicable to the optimization of pediatric dosing of other mAbs and possibly other biologics.

Source: CPT: Pharmacometrics and Systems Pharmacology - January 8, 2024 Category: Drugs & Pharmacology Authors: Zheyi Hu, Sihang Liu, Yue Zhao, Shengnan Du, Lora Hamuro, Jun Shen, Amit Roy, Li Zhu Tags: ARTICLE Source Type: research